Acute myeloid leukemia (AML) is a cancer of immature blood cells. When the early myeloid cell matures normally, it will become either a mature white blood cell, red blood cell, or platelet.

and take a full medical history. Doctors may use the following tests to diagnose AML: Remission induction therapy: This is the first treatment phase, which aims to destroy leukemia cells in the ...

AML represents a disease that develops from the uncontrolled growth and survival of undifferentiated leukemia stem cells. These stem cells are particularly dependent for survival upon the MCL-1 ...

Acute myeloid leukemia (AML) is one of the most aggressive and genetically complex cancers, marked by the unchecked growth of immature myeloid cells. Its diversity stems from numerous genetic ...

The researchers can identify infected mice that develop leukemia, isolate the white blood cells and ... in clinical samples from patients with AML and myelodysplastic syndromes.

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...